BlackRock’s Jade Biosciences, Inc. Common Stock JBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.1M | Buy |
1,714,348
+1,686,940
| +6,155% | +$16.9M | ﹤0.01% | 3079 |
|
|
2025
Q1 | $2.41M | Sell |
27,408
-461
| -2% | -$40.5K | ﹤0.01% | 3888 |
|
|
2024
Q4 | $2.58M | Buy |
27,869
+621
| +2% | +$57.6K | ﹤0.01% | 3914 |
|
|
2024
Q3 | $1.99M | Sell |
27,248
-840
| -3% | -$61.4K | ﹤0.01% | 3950 |
|
|
2024
Q2 | $1.63M | Buy |
28,088
+7,809
| +39% | +$454K | ﹤0.01% | 3973 |
|
|
2024
Q1 | $21M | Sell |
20,279
-505
| -2% | -$523K | ﹤0.01% | 2914 |
|
|
2023
Q4 | $16.5M | Buy |
20,784
+1,276
| +7% | +$1.01M | ﹤0.01% | 3054 |
|
|
2023
Q3 | $9.27M | Buy |
19,508
+1,718
| +10% | +$816K | ﹤0.01% | 3329 |
|
|
2023
Q2 | $10.7M | Buy |
17,790
+647
| +4% | +$388K | ﹤0.01% | 3320 |
|
|
2023
Q1 | $12.1M | Sell |
17,143
-228
| -1% | -$161K | ﹤0.01% | 3146 |
|
|
2022
Q4 | $17.8M | Sell |
17,371
-3,070
| -15% | -$3.15M | ﹤0.01% | 3043 |
|
|
2022
Q3 | $11.9M | Buy |
20,441
+288
| +1% | +$167K | ﹤0.01% | 3269 |
|
|
2022
Q2 | $11M | Sell |
20,153
-1,188
| -6% | -$650K | ﹤0.01% | 3385 |
|
|
2022
Q1 | $13.7M | Buy |
21,341
+489
| +2% | +$314K | ﹤0.01% | 3329 |
|
|
2021
Q4 | $8.61M | Buy |
20,852
+7,051
| +51% | +$2.91M | ﹤0.01% | 3700 |
|
|
2021
Q3 | $10.1M | Buy |
+13,801
| New | +$10.1M | ﹤0.01% | 3609 |
|